Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes.
David C KlonoffBruce W BodeNathan CohenMarc PennW Blair GehoDouglas B MuchmorePublished in: Diabetes care (2019)
Hepatic biodistribution of HDV-L appears to potentiate insulin effect in T1D, with divergent clinical outcomes in hypoglycemia dependent on baseline A1C.